JD Bioscience

본문 바로가기
사이트 내 전체검색
닫기

Company History

2023

12

Complete Phase I clinical study of NASH

07

Nominated top 5 for the "StarinTech BIO" Season 2

05

Selected for "Technology service support project for the next-generation medical research base development" by K-MEDI hub

04

Selected for "Research fund for the Phase I clinical study" by KDDF

2022

09

Commencing Phase I clinical study of the NASH asset

09

07

Submission for TGA approval of Phase I clinical study of the NASH pipeline

07

03

Establishment of an Australian branch, JD Bioscience AU PTY LTD

03

01

Signed collaborative research contracts with 2 ventures

01

2022
2021

04 - 08

Signed collaborative research contracts with 3 ventures

01 - 03

Raised $18 million in Series B funding from investors

- Mirae Asset Capital
- Hyundai Venture Investment
- BSK Investment
- Synergy IB investment
- SV Investment
- Daily Partners
- SJ Investment Partners
- WONIK Investment partners
- Innopolis Partners
- K2 Investment
- UTC Investment

Signed collaborative research contracts with 2 pharma companies

2020

06

Selected for a biomedical technology development business project
by the ministry of Science and ICT ('20.06~'24.12)

06

Selected for a Post-TIPS R&D business project by the Ministry of
SMEs and Startups ('20.06~'22.05)

05

Selected for the development of the energy safety technology
program by the Ministry of Trade, Industry and Energy ('20.05~'23.12)

05

04

Signed a collaborative research contract with Innovo Therapeutics
(INNOVO THERAPEUTICS)

04

01

Selected for a Development of hospitals into the innovation hubs of
the research ecosystem by the Ministry of Health and Welfare ('20.01~'22.12)

01

Signed collaborative research contract with 3 ventures

2020
2019

10

Entered the pre-clinical trial for the main pipeline
(a novel drug candidates for NASH)

07

Signed collaborative research contracts with 3 bio ventures

03

Opened the Seoul office
Established the R&D center at GIST, Gwangju

02

Raised $4.4 million in Series A funding from investors

- Mirae Asset Capital
- Hyundai Venture Investment
- BSK Investment
- Synergy IB investment
- Opez Investment

2018

08

License-in 2 assets from Gwangju institute of science and technology

06

Selected for the Stepping Stone program of the ministry
of SMEs and Startups

05

Increase in capital stock

02

Obtained "Venture business" certification by KIBO
Selected U-Tech valley platform, KIBO

2018
2017

Selected for the TIPS R&D business project by the Ministry of
SMEs and Startups ('17.10~'19.09)

10

Raised a seed capital through Sunbo Angel Partners

08

Established JD BIOSCIENCE Inc.

07

회원로그인

회원가입

사이트 정보

회사명 : 회사명 / 대표 : 대표자명
주소 : OO도 OO시 OO구 OO동 123-45
사업자 등록번호 : 123-45-67890
전화 : 02-123-4567 팩스 : 02-123-4568
통신판매업신고번호 : 제 OO구 - 123호
개인정보관리책임자 : 정보책임자명

  • 게시물이 없습니다.

접속자집계

오늘
77
어제
180
최대
1,191
전체
161,280
Privacy policy

COPYRIGHT(C) 2021 JD BIOSCIENCE INC. ALL RIGHT RESERVED